Clinical Trial Update: Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 1/2 clinical trial evaluating intravenous infusion of allogeneic mesenchymal stem cells derived from Wharton’s je…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Pulmonary Hypertension
• Systemic Sclerosis

Drugs mentioned

• Wharton's Jelly Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Fundación Neumologica Colombiana | Conditions: Systemic Sclerosis Pulmonary, Pulmonary Hypertension | Phase 1, Phase 2 | Status: COMPLETED